A Motor Learning Intervention to Target Walking Performance in Ambulant Children With Cerebral Palsy

NCT ID: NCT06454656

Last Updated: 2024-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

14 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-12

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn if a new therapy approach to improve walking ability in children with Cerebral Palsy is acceptable to the children and the families in a community setting.

The main questions we look to answer are:

1. Do the children/teens tolerate the therapy and feel that it is helpful?
2. Do the parents/ families feel the therapy helps and is easy to commit to?
3. Do the children/teens complete all their therapy sessions and assessments as planned?

The participants will trial the therapy for 30 hours over 6 weeks and will perform assessments before and after to see if they meet their goals. They will also be interviewed to see how they felt about the therapy when they finish.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The therapy being trialed in this study uses motor learning theory to try and improve or change walking patterns to improve the child/teen's walking goal.

Therapy will target their own walking goal and they can choose the format of their therapy as long as they complete 30 hours of which 24 hours must be in the clinic within a 6 week period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy Walking, Difficulty Spastic Diplegia Hemiplegic Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Feasibility Study
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Participants will undergo 30 hours of therapy over 6 weeks in format of their choosing.

A minimum of 24 hours must be completed in clinic with the rest made up of home program.

Group Type EXPERIMENTAL

MOBILE

Intervention Type OTHER

Intensive motor learning based intervention to target specific walking goals as identified using the Gait Outcome Assessment List.

Full Protocol outlining strategies available on request.

Three key principles underpin the intervention:

Principle 1: The type of task

Principle 2: The type of practice

Principle 3: The type of Feedback

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MOBILE

Intensive motor learning based intervention to target specific walking goals as identified using the Gait Outcome Assessment List.

Full Protocol outlining strategies available on request.

Three key principles underpin the intervention:

Principle 1: The type of task

Principle 2: The type of practice

Principle 3: The type of Feedback

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

MOtor learning Based Intervention for Lower Extremities

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary diagnosis of Cerebral Palsy (GMFCS Levels I-III)
* Has a specific walking related goal
* Has capacity to follow instruction
* Has a primary caregiver who can support a home program

Exclusion Criteria

* Has had surgery within 6 months of intervention start date
* Has had botox/ baclofen within 3 months of intervention start date
* Has a dual diagnosis that impacts ability to follow instruction
* Has a significant cognitive impairment
Minimum Eligible Age

6 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Royal College of Surgeons, Ireland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Catriona O'Shaughnessy

Professional Doctorate Scholar

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ailish Malone, PHD

Role: PRINCIPAL_INVESTIGATOR

Royal College of Surgeons

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Enable Ireland Bangla Therapy Centre

Balrath, Meath, Ireland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Ireland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Caitriona M O'Shaughnessy

Role: CONTACT

0833128927

Ailish Malone, PHD

Role: CONTACT

+3531-4022392

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Caitriona M O'Shaughnessy, BSc

Role: primary

0833128927

Lorna Gough, BA Hons

Role: backup

01 8240696

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

23-163

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.